Defunct Company
Total Trials
12
As Lead Sponsor
7
As Collaborator
5
Total Enrollment
1,198
NCT00589212
GliaSite 1-3 Mets Study
Phase: Phase 2
Role: Collaborator
Start: Oct 31, 2003
Completion: Mar 31, 2008
NCT00376103
Radiation Boost for Newly Diagnosed Glioblastoma Multiforme
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 31, 2006
Completion: Not specified
NCT00557375
Brain Tumor Treatment Satisfaction Survey
Phase: N/A
Start: Jun 1, 2007
Completion: Mar 1, 2009
NCT00548938
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
Start: Oct 31, 2007
Completion: Oct 31, 2010
NCT00603824
Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)
Phase: Phase 4
Start: Jan 31, 2008
Completion: Jul 31, 2010
NCT00977405
Collagen-Gentamicin Implant in the Treatment of Contaminated Surgical Abdominal Wounds
Start: Sep 30, 2009
Completion: Aug 31, 2013
NCT01042574
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
Start: May 31, 2010
Completion: Dec 31, 2010
NCT03828058
Envarsus XL Immunosuppression Following Liver Transplantation
Start: Apr 1, 2019
Completion: Dec 31, 2020
NCT04267744
Remote Monitoring of Multiple Indicators of Heart Failure
Start: Feb 11, 2020
Completion: Aug 1, 2024
NCT05604144
Cryoanalgesia for the Treatment of Pain in Subjects With Morton's Neuroma
Start: Aug 22, 2022
Completion: Apr 22, 2023
NCT05347238
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
Start: Feb 6, 2023
Completion: Mar 31, 2027
NCT07144306
AI-Driven Early Detection of Skin Cancer
Start: Oct 1, 2025
Completion: Jan 1, 2026